J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Rang in aandelen
#3893
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Aandeelprijs
$26.58
Laatst gesynchroniseerd: 2026-07-23
Marktkapitalisatie
$4.24B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
38.40%
Land
IN
Handel J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Categorie
Healthcare
P/B-ratio voor J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
P/B-ratio op October 2026 TTM: 9.27
Volgens de meest recente financiële rapporten en aandelenkoers van J. B. Chemicals & Pharmaceuticals Limited is de huidige P/B-ratio (TTM) 9.27. Eind 2024 had het bedrijf een P/B-ratio van 8.99.
P/B-ratiohistoriek voor J. B. Chemicals & Pharmaceuticals Limited van 2005 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 9.27 | 29.34% |
| 2025 | 7.17 | -20.26% |
| 2024 | 8.99 | 45.87% |
| 2023 | 6.16 | 7.98% |
| 2022 | 5.71 | 6.43% |
| 2021 | 5.36 | 91.96% |
| 2020 | 2.79 | 36.00% |
| 2019 | 2.05 | 12.86% |
| 2018 | 1.82 | -15.48% |
| 2017 | 2.15 | 11.29% |
| 2016 | 1.93 | 13.81% |
| 2015 | 1.70 | 63.33% |
| 2014 | 1.04 | 64.51% |
| 2013 | 0.63 | 18.87% |
| 2012 | 0.53 | -67.05% |
| 2011 | 1.62 | 53.39% |
| 2010 | 1.05 | 60.86% |
| 2009 | 0.65 | -29.39% |
| 2008 | 0.93 | -41.37% |
| 2007 | 1.58 | -43.38% |
| 2006 | 2.79 | 19.52% |
| 2005 | 2.34 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -45.64% |
IN
|
